Research Article | Volume: 7, Issue: 8, August, 2017

Nano-Se crosstalks with nano-DOX/FU to selectively hack hepatic cancer cells and spare normal cells healthy: A mechanism-based study

Aziza B. Shalby Ahmed A. Abd-Rabou Hanaa H. Ahmed   

Open Access   

Published:  Aug 30, 2017

DOI: 10.7324/JAPS.2017.70802
Abstract

Egypt became as one of the hot spots in the international map of hepatocellular carcinoma (HCC). HCC is the second cancer type in Egyptian men and the sixth in Egyptian women. Selenium (Se) is one of the known essential elements for human beings, its deficiency is linked with aliments, while its dosage over the recommended daily allowance appears to protect against some cancer types. The purpose of the present study was to hack hepatic cancer cells and spare normal cells healthy using the crosstalk mechanism of nano-Se with nano-DOX or nano-FU. We used liver cancer HepG2 versus normal kidney BHK-21 cell lines as models to investigate the antiproliferative action of Se, FU (5-fluorouracil), and DOX (doxorubicin) nanoformulations. We recorded that individual treatments with nano-Se, nano-FU, or nano-DOX promote both HepG2 and BHK-21 cell death in a dose dependent manner. On the contrary, nano-FU or nano-DOX when combined with nano-Se selectively triggers HepG2 cell death, while sparing BHK-21 cells proliferating in a healthy state. Moreover, Se nanoformulation potentiates nitric oxide (NO) and malondialdehyde (MDA) re-homeostasis when combined with DOX and FU nanoformulations to avoid harming BHK-21 normal cells; this is associated with slight bioenergetic deprivation through glycolytic inhibition. Interestingly, we also observed that individual and combinatorial Se nanoformulation crosstalks with Zinc to kill cancer cells. Conclusively, targeting of redox mode and glucose consumption using Se, FU, DOX nanoformulations may provide a new vision for tackling hepatocellular carcinoma specifically, not normal cells.


Keyword:     Nano-Se nano-FU nano-DOX HepG2 cell line tumor inhibition.


Citation:

Shalby AB, Abd-Rabou AA, Ahmed HH. Nano-Se crosstalks with nano-DOX/FU to selectively hack hepatic cancer cells and spare normal cells healthy: A mechanism-based study. J App Pharm Sci, 2017; 7 (08): 003-012.

Copyright: © The Author(s). This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

HTML Full Text

Reference

Article Metrics
415 Views 14 Downloads 429 Total

Year

Month

Related Search

By author names